How to conduct clinical trials?

Clinical trials are conducted in phases. Each phase is proposed to answer specific concerns while also taking the necessary precautions to protect those taking part. Before regulatory organizations deem a new medicine safe and effective, it is normally studied in three rounds of clinical trials. Trials are also carried out in accordance with Good Clinical Practice (GCP) principles, which are mandated by authorities in order to preserve patient safety.

⇒ Check our Blog for guidance on Understanding Incidence and Prevalence in Toxicology: Biostatistics and Epidemiology Principles

Conducting clinical trials is a complex and highly regulated process designed to evaluate the safety and effectiveness of new medical treatments, therapies, Biostatistics Program or interventions in humans. These trials are essential for advancing medical knowledge and bringing new treatments to patients. Here’s a general overview of the steps involved in conducting clinical trials:

1. Study Design and Protocol Development:
   • Define the research question or hypothesis that the trial aims to address.
   • Develop a detailed study protocol outlining the trial’s objectives, eligibility criteria for participants, treatment plans, and study procedures. This protocol must be approved by an Institutional Review Board (IRB) or Ethics Committee.
2. Recruitment and Informed Consent:
   • Recruit eligible participants based on the defined criteria.
   • Obtain informed consent from all participants, ensuring they fully understand the study’s purpose, procedures, risks, and biostatistical analysis potential benefits.
3. Randomization and Blinding:
   • Randomly assign participants to different treatment groups (if applicable) to reduce bias.
   • Implement blinding (single-blind, double-blind, or triple-blind) to prevent bias in data collection and analysis.
4. Treatment Administration and Monitoring:
   • Administer the investigational treatment or biostatistical interpretation to participants according to the protocol.
   • Monitor participants closely, collect data, and document any adverse events or side effects.
5. Data Collection and Analysis:
   • Collect data on participants’ health outcomes, using standardized methods and instruments.
   • Analyze the data to determine the safety and efficacy of the treatment..
   • Use statistical methods to assess the significance of the results.
6. Reporting and Publication:
   • Prepare a comprehensive report of the trial’s findings, including both positive and negative results.
   • Submit results to regulatory authorities, such as the FDA (U.S. Food and Drug Administration), and publish findings in scientific journals.
7. Regulatory Compliance:
   • Comply with all relevant regulatory requirements and guidelines specific to your region or country.
   • Maintain thorough records of the trial’s conduct, data, and adverse events.
8. Ethical Considerations:
   • Ensure that the trial adheres to ethical principles and safeguards the rights and well-being of participants.
   • Obtain ongoing approval from the IRB or Ethics Committee.
9. Safety Monitoring and Adverse Event Reporting:
   • Continuously monitor participants for adverse events and promptly report them to regulatory authorities as required.
10. Phase Advancement (for multi-phase trials):
    • If a trial progresses through multiple phases (e.g., Phase I, Phase II, Phase III), carefully assess the results of each phase before moving to the next.
11. Post-Market Surveillance (Phase IV):
    • After approval and commercialization, continue monitoring the treatment’s safety and effectiveness in real-world settings (Phase IV).
12. Collaboration and Communication:
    • Collaborate with research partners, investigators, and sponsors to ensure the trial’s success.
    • Analyze the data to determine the safety and efficacy of the treatment.
    • Maintain transparent communication with participants, regulators, and the scientific community.

⇒  Check our Biostatistics examples to know and how the Biostatistics sample is structured.

It’s important to note that clinical trials can take several years to complete, involve significant financial resources, and require meticulous planning and execution. Quantitative Research must follow strict guidelines and regulations to ensure the validity and reliability of the trial’s results. Additionally, clinical trials may be conducted by academic institutions, pharmaceutical companies, or government agencies, and Pubrica supports the specific processes and regulatory requirements may vary based on the nature of the study and the region in which it is conducted.